- Home
- TVTX vs NBXG Comparison
TVTX vs NBXG Comparison
Compare TVTX & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- NBXG
- Stock Information
- Founded
- TVTX 2008
- NBXG 2021
- Country
- TVTX United States
- NBXG United States
- Employees
- TVTX N/A
- NBXG N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- NBXG Trusts Except Educational Religious and Charitable
- Sector
- TVTX Health Care
- NBXG Finance
- Exchange
- TVTX Nasdaq
- NBXG Nasdaq
- Market Cap
- TVTX 1.4B
- NBXG 1.1B
- IPO Year
- TVTX N/A
- NBXG N/A
- Fundamental
- Price
- TVTX $15.63
- NBXG $14.47
- Analyst Decision
- TVTX Strong Buy
- NBXG
- Analyst Count
- TVTX 16
- NBXG 0
- Target Price
- TVTX $33.33
- NBXG N/A
- AVG Volume (30 Days)
- TVTX 1.2M
- NBXG 243.7K
- Earning Date
- TVTX 08-06-2025
- NBXG 01-01-0001
- Dividend Yield
- TVTX N/A
- NBXG 10.25%
- EPS Growth
- TVTX N/A
- NBXG N/A
- EPS
- TVTX N/A
- NBXG N/A
- Revenue
- TVTX $273,533,000.00
- NBXG N/A
- Revenue This Year
- TVTX $71.61
- NBXG N/A
- Revenue Next Year
- TVTX $43.45
- NBXG N/A
- P/E Ratio
- TVTX N/A
- NBXG N/A
- Revenue Growth
- TVTX 75.65
- NBXG N/A
- 52 Week Low
- TVTX $7.93
- NBXG $9.31
- 52 Week High
- TVTX $25.29
- NBXG $12.23
- Technical
- Relative Strength Index (RSI)
- TVTX 49.00
- NBXG 48.86
- Support Level
- TVTX $15.28
- NBXG $14.69
- Resistance Level
- TVTX $15.97
- NBXG $15.02
- Average True Range (ATR)
- TVTX 0.62
- NBXG 0.18
- MACD
- TVTX -0.06
- NBXG -0.05
- Stochastic Oscillator
- TVTX 28.78
- NBXG 12.04
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".